Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Phase Ib/II Study of Pamiparib Plus Radiation Therapy and/or Temozolomide in Adult Patients with Treatment-Naïve or Recurrent/Refractory Glioblastoma.
Journal: Current oncology (Toronto, Ont.)
Published: July 25, 2025
A phase Ib study evaluating the c-MET inhibitor INC280 (capmatinib) in combination with bevacizumab in patients with high-grade glioma.
Journal: Neuro-oncology advances
Published: February 10, 2025
A pilot survey into the landscape of neuro-oncology care in the community.
Journal: The oncologist
Published: October 01, 2024
Avelumab in patients with previously treated metastatic Merkel cell carcinoma (JAVELIN Merkel 200): updated overall survival data after >5 years of follow-up.
Journal: ESMO open
Published: June 09, 2021
Avelumab in patients with previously treated metastatic Merkel cell carcinoma: long-term data and biomarker analyses from the single-arm phase 2 JAVELIN Merkel 200 trial.
Journal: Journal for immunotherapy of cancer
Published: April 07, 2020
Phase I/II study of bevacizumab with BKM120, an oral PI3K inhibitor, in patients with refractory solid tumors (phase I) and relapsed/refractory glioblastoma (phase II).
Journal: Journal of neuro-oncology
Published: April 01, 2019
Regorafenib Prior to Selective Internal Radiation Therapy Using 90Y-Resin Microspheres for Refractory Metastatic Colorectal Cancer Liver Metastases: Analysis of Safety, Dosimetry, and Molecular Markers.
Journal: Frontiers in oncology
Published: March 13, 2019
Early objective response to avelumab treatment is associated with improved overall survival in patients with metastatic Merkel cell carcinoma.
Journal: Cancer immunology, immunotherapy : CII
Published: August 28, 2018
Clinical activity and safety of atezolizumab in patients with recurrent glioblastoma.
Journal: Journal of neuro-oncology
Published: May 10, 2018
A First-in-Human Study of Novel Cereblon Modulator Avadomide (CC-122) in Advanced Malignancies.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 23, 2018
Randomized Phase II Study Evaluating Akt Blockade with Ipatasertib, in Combination with Abiraterone, in Patients with Metastatic Prostate Cancer with and without PTEN Loss.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 28, 2018
Last Updated: 09/26/2026